Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

Savara Q3 2026 Results: Net Loss of $43M, Loss Widens

Savara Inc. reported a net loss of $120.5 million for the nine months ended September 30, 2026, compared to $86.6 million in the prior year, driven by increased R&D and G&A expenses. The company's cash and short-term investments decreased to $129.6 million from $235.7 million at the end of 2025. Total stockholders' equity declined to $107.9 million as the company continues to fund its clinical development programs.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Net income-43.0-29.6
EPS (diluted, $ a share)$-0.17$-0.14

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, NASDAQ: SVRA. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

Savara Inc: key numbers

Share price
$4.47Close, Nov 16
Market cap
$985M
Shares outstanding
220.62MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.